MoneyWorks4Me

Balaxi Pharma. - Quaterly Results

02 Aug 2024 Evaluate
The sales is pegged at Rs. 190.26 millions for the June 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 250.40 millions during the year-ago period.Net profit of the cmpany stood at Rs. 13.76 millions for the quarter ended June 2024 a decline of -46.12% from Rs. 25.54 millions  in the same quarter last year.Operating Profit reported a sharp decline to 23.56 millions from 38.97 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 190.26 250.40 -24.02 190.26 250.40 -24.02 701.96 1081.38 -35.09
Other Income 8.45 1.26 570.63 8.45 1.26 570.63 23.99 66.04 -63.67
PBIDT 23.56 38.97 -39.54 23.56 38.97 -39.54 76.35 234.26 -67.41
Interest 3.54 2.58 37.21 3.54 2.58 37.21 15.41 4.59 235.73
PBDT 20.02 36.39 -44.98 20.02 36.39 -44.98 60.94 229.67 -73.47
Depreciation 1.15 1.31 -12.21 1.15 1.31 -12.21 5.11 5.15 -0.78
PBT 18.87 35.08 -46.21 18.87 35.08 -46.21 55.83 224.52 -75.13
TAX 5.11 9.54 -46.44 5.11 9.54 -46.44 19.33 62.29 -68.97
Deferred Tax -0.19 -0.03 533.33 -0.19 -0.03 533.33 -1.05 10.62 -109.89
PAT 13.76 25.54 -46.12 13.76 25.54 -46.12 36.50 162.23 -77.50
Equity 110.42 102.30 7.94 110.42 102.30 7.94 108.98 101.81 7.04
PBIDTM(%) 12.38 15.56 -20.43 12.38 15.56 -20.43 10.88 21.66 -49.79
Peers